We have detected that you are using an Ad Blocker. PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Explore
Metastatic Breast Cancer
Center of Excellence
Interested in receiving weekly updates about the Metastatic Breast Cancer Center of Excellence?
You can find your saved items on your dashboard, in the "saved" tab.
You've recommended your first item
Your recommendations help us improve our content suggestions for you and other PracticeUpdate members.
You've subscribed to your first topic alert
What does that mean?
Each day, we'll check to see if new items have been published to the topics you're subscribed to, and we'll send you one email with all of the new items from that day.
We'll keep all topic alert notifications available on your dashboard for 30 days, to make sure you don't miss anything.
Lastly, whenever you have unread items in the topics you've subscribed to, the "Alerts" icon will light up in the main menu. Just click on the bell to see your five most-recent, unread notifications.
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
No comments yet, be the first to start the discussion!
luis betancourt
Apr 30, 2019
hormonal tx and re-evaluation in 2-3 months
hsien tang yeh
May 03, 2019
under sona-guided FNA of axillary LN to prove metastasis indicated, as after neoadjuvant treatment, the axillary surgery option depends on pre-treatment and post-treatment condition,Ki 67 count also a predict factor as chemo or hormone be the first treatment.
Luca Licata
May 03, 2019
Is there the possibility to enroll the patient in a neoadjuvant clinical trial with hormonal therapy and cdk4/6 inhibitors?
surapong supaporn
May 03, 2019
LuA; neo endocrine tx
LuB, TC
The node; should be bx
Sewa Legha
May 03, 2019
This is a very high risk situation with bilateral Breast Cancer, with locally advanced disease on one side . Therefore she will need all modalities of treatment including chemo, endocrine therapy, surgery and most likey XRT at the end of systemic therapy.. As she will need both hormonal therapy and chemotherapy, these will need to be used sequentially. Since the neoadjuvant endocrine therapy experience is much more limited in comparison to neoadjuvant chemotherapy, I would recommend starting with Neoadjuvant chemo using a combination of 2 cytotoxic agents followed by local therapy (?bilateral mastectomy) and at the end using endocrine therapy as adjuvant therapy.
Oda Abushaban
May 29, 2019
In rt axilla need for sentinel L N biopsy to confirm diagnosis
May 08, 2024
Pending Moderator approval.
Are you sure you want to delete this comment? This can't be undone.
luis betancourt
Apr 30, 2019
hsien tang yeh
May 03, 2019
Luca Licata
May 03, 2019
surapong supaporn
May 03, 2019
Sewa Legha
May 03, 2019
Oda Abushaban
May 29, 2019
May 08, 2024
Pending Moderator approval.